In a press statement, SESARAM released a response to an article published today in Diário de Notícias about the perceived lack of medicines available in the region.
Regional budgets for prescription drugs have increased, with funding for cancer medication reaching 30 million euros in 2024. The article suggested that with the amount of money being spent, SESARAM should be able to guarantee that patients have access to the drugs they need.
However, SESARAM admits they face logistical difficulties, such as transportation delays and supply disruptions, especially for medicines exclusive to certain suppliers. They used, as an example. ‘ENCORIFENIB,’ which should be delivered by the end of the week. Encorifenib is used in certain types of melanoma cancers.
Samantha Gannon
info at madeira-weekly.com
